1 / 43

Cephalosporins

Cephalosporins. Cephalosporin antibiotics derived from “cephalosporin C” obtained from fungus Cephalosporium acremonium Cephalosporin nucleus Consists of dihydrothiazine ring fused to a β –lactam ring 7-aminocephalosporanic acid.

Ava
Download Presentation

Cephalosporins

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cephalosporins

  2. Cephalosporin antibiotics • derived from “cephalosporin C” • obtained from fungus Cephalosporium acremonium • Cephalosporin nucleus Consists of dihydrothiazine ring fused to a β–lactam ring • 7-aminocephalosporanic acid

  3. 7-aminocephalosporanic acid has been modified by addition of different side chains to create a whole family of cephalosporin antibiotics. • these have been conventionally divided into 5 generations

  4. Mechanism of action • All cephalosporins are bactericidal. • MOA same as penicillin- Inhibit cell wall synthesisin a manner similar to penicillins • Bind to different proteins than those which bind penicillin. PBP-1 &PBP-3 • This explains diffenece in spectrum, potency & lack of resistance.

  5. Inhibition of transpeptidation • Imperfect cell wall • Osmotic drive • Activation of autolysin enzymes • Lysis of bacteria • BACTERICIDAL

  6. CLASSIFICATION • Based on • antimicrobial spectrum • Chronological sequence of development • Divided into generations.

  7. First-generation agents • Cephalexin (O) • Cefadroxil (O) • Cefazolin (i.m, i.v) • Cefalothin (withdrawn)

  8. Exhibit good activity against gram-positive bacteriabut modest activity against gram negative organisms. • Most gram-positive cocci • Strepto, • Pneumo, • Methicillin sens. Staph. are susceptible to first-generation cephalosporins • Modest activity against E. coli, K. pneumoniae & Proteus mirabilis Most oral cavity anaerobes are sensitive.  However, the Bacteroidesfragilis group is resistant.

  9. Second-generation agents • Cefaclor (O) • Ceforanide • Cefuroxime acetil (O) • Cefuroxime (i.m , i.v) • Cefoprozil • Cefamandole (Banned) • Cefoxitin (Banned) • Cefotetan (Banned)

  10. Exhibit somewhat increased activity against gram negative organisms, • but much less active than third generation agents. • Less active against gram positive cocci & bacilli compared to first gen. drugs. • Use declined • Clinically replaced by 3rd & 4th generation drugs .

  11. Third-generation agents • Cefotaxime • Ceftriaxone • Cefdinir • Cefibuten • Cefpodoxime • Ceftizoxime • Ceftazidime • Cefoperazone (withdrawn)

  12. Highly augmented activity against gram-negative organisms • Less active than first generation agents against gram positive cocci & anaerobes. • All are highly resistant to β-lactamases from gram negative bacteria. • Some inhibit psuedomonas as well; ceftazidime, cefoperazone(withdrawn)

  13. Some members of this group have enhanced ability to cross the blood-brainbarrier eg. Ceftriaxone and are effective in treating meningitis caused by pneumococci, meningococci, H. influenzae and susceptible gram negative rods.

  14. Fourth-generation agents • Cefpirome P/E (im/iv) • Cefepime P/E (iv) • Cefozopran P/E

  15. Highly active against G –ve organisms • Similar to third gen drugs for g +ve bacteria • The fourth generation drugs comparable to third generation but more resistant to hydrolysis by β-lactamases. • Effective against bacterial infections resistant to earlier drugs

  16. Fifth-generation agents • Ceftobiprole • Ceftaroline • Active against, g +ve cocci especially MRSA • penicillin resistant S. pneumoniae • and enterococci

  17. Resistance • Impermeability to the antibiotic. • to reach its site of action • Alteration in PBPs -antibiotics bind with low affinity • Elaboration of β-lactamases; that can hydrolyze the β-lactam ring and inactivate the cephalosporin (most prevalent mech)

  18. Adverse reactions • Pain after im injection • Thrombophlebitis of injected vein. • Diarrhoea more common with • oralCeferadine • P/ECefoperazone (Banned)

  19. Hypersensitivityreactions • Identical to penicillins, incidence is lower. • shared β-lactam structure • Allergic to penicillins- allergic to cephalosporins. CROSS-REACTIVITY. • Rashes, frequent, anaphylaxis, angioedema, asthma, urticaria have also occurred.

  20. Cephalosporins potentially nephrotoxicdrugs • Cephaloridine(withdrawn) RTN • Cephalothin (withdrawn) Acute tubular necrosis • Serious bleeding • Cefoperazone(Banned), • Moxalactam(Banned). • Due to hypoprothrombinemia.

  21. Intolerance to alcohol Disulfiram like reaction • Cefamandole (Banned) • Cefotetan (Banned) • Moxalactam (Banned) • Cefoperazone (Banned)

  22. Therapeutic Uses • Extensively used & therapeutically important antibiotics • Effective therapeutic & prophylactic agents

  23. First Gen agents • Excellent for skin & soft tissue infections • Surgical prophylaxis first generation drugs are the preferred for prophylaxis in procedures in which skin flora are likely pathogens.

  24. Second Gen agents • Displaced by third generation agents for Gram negative infections • Oral-RTI (replaced by augmentin)

  25. Third Gen agents • With/without aminoglycosides DOC- severe G -ve infections caused by • Kleibsiella • Enterobacter • Proteus • Providencia • Serratia & haemophillus species.

  26. Ceftriaxone is the therapy of choice for all forms of Gonorrhea • 250 mg i.m as single dose • i.v ceftriaxone for enteric fever • Cefotaxime & ceftriaxone • Community aquired pneumonia

  27. Cefotaxime/ceftriaxone are used for initial treatment of meningitis because of their • antimicrobial activity, • good penetration into CSF • & record of clinical success • They are DOC - Meningitis due to • H. influenzae • Sensitive S. pneumonae • N. meningitidis • G-ve enteric bacteria • Ceftazidime + aminoglycosides • Psuedomonas meningitisDOC

  28. Fourth Generation Agents • Same as third generation drugs • Indicated for hospital acquired infections resistant to commonly used antibiotics

  29. Other β -lactam antibiotics

  30. Other β -lactam antibiotics • Newer classes of β-lactam antibiotics are the • Monobactams • Carbapenems • Carbacephems • Important therapeutic agents with a β-lactam structure & are neither penicillins nor cephalosporins

  31. Monobactams Aztreonam • Isolated from chromobacterium violaceum • Only monobactam currently in clinical use • β - lactam ring, lacking the thiazolidine ring. - a monobactam

  32. Antimicrobial activity differs from those of other β -lactam antibiotics & more closely resembles that of an aminoglycoside • Primarily affects : • Aerobic gram negative microorganisms • gram positive bacteria & anaerobic organisms are resistant • Preferred-all sorts of gram negative infections in patients with renalimpairment where aminoglycosides are to be avoided.

  33. Stable to most β-lactamases elaborated by gram negative bacteria. • i.m / i.v • Therapeutic conc. inCSF in the presence of inflammed meninges, Alternative to cephalosporins for therapy of meningitis caused by G-ve bacilli

  34. Carbapenems • β-lactam antibiotic • Broader spectrum of activity : than most other β-lactams . • gram-negative rods • gram-positive bacteria • and anaerobes.

  35. Carbapenems • Imipenem • Meropenem • Ertapenem

  36. Imipenem • Derived from compound produced by Streptomycescattleya • Mechanism same as penicillins • Bactericidal • Resistant to hydrolysis by β-lactamase • Marketed in combination with cilastin • Inhibits degradation – by renal dipeptidase • Without cilastin renal dehydropeptidases inactivate the drug which results in low urinary tract concentrations.

  37. Adverse effects • Nausea ,vomiting • Seizures • Patients allergic to other β-lactam antibiotics may have hypersenstivity reactions when given imipenem

  38. Meropenem • Therapeutic equivalence with imipenem • Coadministration with cilastin not required • Meropenem is less seizure producing compared to imipenem.

  39. Ertapenem • Differs from imipenam & meropenem largerserum half life, OD. • Co-administration with cilastin not required • less seizure producing compared to imipenem.

  40. All are parenteral • i.v, im painful • Imipenem 6 hrly • Meropenam 8 hrly • All are resistant to β – lactamases • All bactericidal • MOA same • Patients allergic to other β-lactam antibiotics may have hypersenstivity reactions when given imipenem/carbapenems.

  41. Therapeutic uses • Urinary tract infections • Lower respiratory tract infections • Intra-abdominal & gynaecological infections • Skin, bone, joint, & soft tissue infections • Especially cephalosporin/ penicillin resistant nosocomial bacteria.

  42. Carbacephems Loracarbef • Synthetic β-lactam antibiotic • Similar to cefaclor • Antibacterial activity resembles II generation cephalosporins.

More Related